BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 15183471)

  • 1. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
    Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer: optimizing dose escalation.
    Vicini FA; Kestin LL; Martinez AA
    Tech Urol; 2000 Jun; 6(2):135-45. PubMed ID: 10798815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment.
    Stromberg JS; Martinez AA; Horwitz EM; Gustafson GS; Gonzalez JA; Spencer WF; Brabbins DS; Dmuchowski CF; Hollander JB; Vicini FA
    Cancer J Sci Am; 1997; 3(6):346-52. PubMed ID: 9403047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
    Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
    Seung SK; Kroll S; Wilder RB; Posner MD; Roach M
    Cancer J Sci Am; 1998; 4(3):168-74. PubMed ID: 9612598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up.
    Ragde H; Korb LJ; Elgamal AA; Grado GL; Nadir BS
    Cancer; 2000 Jul; 89(1):135-41. PubMed ID: 10897010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor control of locally advanced prostate cancer following combined estramustine, vinblastine, and radiation therapy.
    Khil MS; Kim JH; Bricker LJ; Cerny JC
    Cancer J Sci Am; 1997; 3(5):289-96. PubMed ID: 9327153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure pattern implications following external beam irradiation of prostate cancer: long-term follow-up and indications of cure.
    Hanlon AL; Hanks GE
    Cancer J; 2000 Apr; 6 Suppl 2():S193-7. PubMed ID: 10803836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma.
    Zelefsky MJ; Leibel SA; Kutcher GJ; Kelson S; Ling CC; Fuks Z
    Cancer J Sci Am; 1995; 1(2):142-50. PubMed ID: 9166467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer.
    Deger S; Dinges S; Roigas J; Schnorr D; Turk I; Budach V; Hinkelbein W; Loening SA
    Tech Urol; 1997; 3(4):190-4. PubMed ID: 9531101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose combination radiotherapy for the treatment of localized prostate cancer.
    Zeitlin SI; Sherman J; Raboy A; Lederman G; Albert P
    J Urol; 1998 Jul; 160(1):91-5; discussion 95-6. PubMed ID: 9628612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiotherapy alone in endometrial neoplasms. The authors' own experience].
    Fusco V; Troiano M; Corsa P; Raguso A; Lioce M; Lauriola P; Parisi S
    Radiol Med; 1998 Jun; 95(6):640-6. PubMed ID: 9717549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol.
    Noyes WR; Bastin K; Edwards SA; Buchler DA; Stitt JA; Thomadsen BR; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1439-43. PubMed ID: 7635785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of bilateral pelvic lymphadenectomy, permanent iodine-125 implantation and percutaneous irradiation of localized prostate carcinoma. 1: Methods and results].
    Thiel HJ; Müller R; Schrott KM
    Strahlenther Onkol; 1987 Mar; 163(3):164-75. PubMed ID: 3105101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-course androgen ablation combined with external-beam radiation therapy and low-dose-rate permanent brachytherapy in early-stage prostate cancer: a matched subset analysis.
    Sylvester J; Blasko JC; Grimm PD; Meier R; Cavanagh W
    Mol Urol; 2000; 4(3):155-9;discussion 161. PubMed ID: 11062369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.
    Mantz CA; Nautiyal J; Awan A; Kopnick M; Ray P; Kandel G; Niederberger C; Ignacio L; Dawson E; Fields R; Weichselbaum R; Vijayakumar S
    Cancer J Sci Am; 1999; 5(4):230-6. PubMed ID: 10439169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report.
    Mate TP; Gottesman JE; Hatton J; Gribble M; Van Hollebeke L
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):525-33. PubMed ID: 9635698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term follow-up of serum prostate-specific antigen after radiotherapy of prostatic carcinoma].
    Schmid HP; Ferrari MK; Stamey TA
    Helv Chir Acta; 1994 Dec; 60(6):1101-5. PubMed ID: 7533148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical radiotherapy of localised prostate cancer: the relationship between radiation dose and survival.
    Magrini SM; Cellai E; Pertici M; Rossi F; Ponticelli P; Odantini R; Cappellini M; Biti GP
    Cancer Radiother; 1998; 2(4):351-8. PubMed ID: 9755748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.